*To the Editor*:

We have read, with great interest, Tobin's article ([@bib1]) and agree with the author that circular thinking is especially dangerous when managing patients and that caregivers must base clinical decisions on sound scientific knowledge. As Tobin says, "In most instances, mechanical ventilation is instituted preemptively out of fear of an impending catastrophe. These patients are receiving mechanical ventilation, and it is impossible to prove that they 'required' it when first implemented." We also agree with what is stated in Tobin's book: "When making decisions about the treatment of an individual patient, however, it is not possible to avoid subjective value judgments (things being assessed on a scale of goodness or badness). Ultimately, the decision of whether to institute mechanical ventilation (or not) boils down to a value judgment by the patient's physician." The ideal situation is to institute mechanical ventilation having previously formulated a precise diagnosis ([@bib2]). In patients with coronavirus disease (COVID-19) complying with the Berlin definition of acute respiratory distress syndrome (ARDS), we have a precise diagnosis. And we should do our best to avoid circular thinking and making value judgments in our decision to institute invasive mechanical ventilation (involving an endotracheal tube).

In the book, Tobin and Laghi "(...) believe \[sic\] that the most honest description of a physician's judgment at this juncture is: 'The patient looks like he (or she) needs to be placed on the ventilator.' That is, a physician institutes mechanical ventilation based on his or her gestalt of disease severity as opposed to slotting a patient into a particular diagnostic pigeonhole." In the scientific reasoning, this raises a good hypothesis deserving refutation with an experiment, and recently, we have one that fits perfectly ([@bib3]). After the enrollment of 205 ventilated patients with ARDS, the LOCO2 (Liberal Oxygenation vs. Conservative Oxygenation in ARDS) investigators and REVA (Réseau Européen de Ventilation Artificielle) Research Network had to prematurely stop a randomized controlled trial because of safety concerns and low likelihood of significant difference between the two groups in the primary outcome. The patients randomized to "conservative oxygen therapy" (target Pa~O~2~~, 55--70 mm Hg; oxygen saturation as measured by pulse oximetry, 88--92%) did not increase survival rates versus those in the "liberal oxygen therapy" (target Pa~O~2~~, 90--105 mm Hg; oxygen saturation as measured by pulse oximetry, ≥96%) group. The differences in mortality at 28 and 90 days were 7.8 (95% confidence interval, −4.8 to 20.6) and 14 (95% confidence interval, 0.7 to 27.2) percentage points, and five mesenteric ischemic events occurred in the conservative group.

This is the key to science: if your hypothesis disagrees with the experiment, it is wrong ([@bib4]). We have an experiment that refutes Tobin's hypothesis. Far from circular thinking and value judgments, scientific reasoning refutes the "conservative" oxygen therapy approach in ventilated patients with ARDS. There is something more consistent than a fear that without mechanical ventilation, COVID-19 will produce organ impairment and death if ARDS has been accurately diagnosed.
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